None listed
Conditions
Interventions
None listed
Sponsors
Dr Keertan M S
Eligibility
Inclusion criteria
Inclusion criteria: 1. Pre-diabetic subjects with HbA1c of 5.7-6.4%. 2. FBS 3. Subject who submit a written informed consent
Exclusion criteria
Exclusion criteria: 1. Known Cases of DM, both type I and II. 2. Past history of gestational diabetes 3. Uncontrolled Hypertensive subjects(with or without medication > 140/90 mmHg) 4. Pregnant / Lactating women. 5. Alcoholics and/or drug abusers 6. Patients suffering from major systemic illness necessitating long term drug treatment (Rheumatoid arthritis, Psycho-Neuroendocrinal disorders, etc.) 7. Any other medical illness like Coronary Artery disease, Stroke etc 8. Patients who have completed participation in any other clinical trial during the past six (06) months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in HbA1c level from baseline and in 90 daysTimepoint: 90 days | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Changes in fasting insulin level from baseline and in 90 days 2.Changes in Homa IR level from baseline and in 90 days 3.Changes in fasting and Post prandial blood sugar from baseline and at 30th, 60th and 90th days 4.Changes in lipid profile from baseline and at 90 days 5.Changes in Liver function tests and Serum creatinine profiles from baseline and at 90 days 6.Changes in BMI and waist circumference at baseline and at 30th , 60th and 90th days 7.Changes in Quality of Life (DQoL): at baseline and at 30th, 60th and 90th days Timepoint: 30th, 60th and 90th days | — |
Countries
India
Contacts
Public ContactDr Keertan M S
KAHER Belagavi
Outcome results
None listed